Showing results (2581-2590 of 9,335) with videos related to
Sort By:
Pageof 934
Cancer Medicine|February 11, 2022
Gastric and esophageal cancer in China 2000 to 2030: Recent trends and short-term predictions of the future burdenJiachen Zhou, Rongshou Zheng, Siwei Zhang, et al.Cancer Medicine|February 11, 2022
Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancerAnnika Eurola, Harri Mustonen, Nora Mattila, et al.Cancer Medicine|May 1, 2019
Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinomaQianwei Xing, Ran Li, Aiming Xu, et al.Cancer Medicine|October 13, 2019
TNPO2 operates downstream of DYNC1I1 and promotes gastric cancer cell proliferation and inhibits apoptosisLibao Gong, Ti Wen, Zhi Li, et al.Cancer Medicine|October 18, 2019
Carbon-ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational studyYukihiro Takayasu, Nobuteru Kubo, Masato Shino, et al.Cancer Medicine|October 18, 2019
The volume of 99m Tc sulfur colloid SPET-defined active bone marrow can predict grade 3 or higher acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapyShan-Bing Wang, Jia-Pei Liu, Kai-Jian Lei, et al.Cancer Medicine|August 11, 2018
Long noncoding RNA MALAT1 regulates HDAC4-mediated proliferation and apoptosis via decoying of miR-140-5p in osteosarcoma cellsYuxiu Sun, Baoli QinCancer Medicine|May 4, 2019
Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute - Mexico, from 2000 to 2016Jimena Ylescas-Soria, Alfredo H de la Torre-Lujan, Luis A Herrera, et al.Cancer Medicine|May 4, 2019
The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndromeLeiming Xia, Yi Wang, Tan Li, et al.Cancer Medicine|May 4, 2019
Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal typeShu Tian, Ruichen Li, Tian Wang, et al.Pageof 934